NLC Health Ventures

NLC Health Ventures, often referred to as NLC, operates from Amsterdam with a distinctive model: rather than investing in companies pitched to it, the firm builds health ventures from European medical research and inventions, partnering with researchers to form, fund, and grow new operating companies. Investment activity spans biotech, medical devices, and digital health. The venture builder approach means NLC is not just a capital provider but a co-founder, taking on more company-building responsibility than a typical venture firm. Limited public information is available about specific named partners attributed to individual ventures in this profile, but the venture builder posture is the firm’s defining feature in the European healthcare innovation landscape.

Check sizes typically run from two hundred fifty thousand to one million dollars at the formation stage, deployed at pre-seed and seed. Geographic focus is Europe, with the firm working primarily with researchers and medical inventors from European institutions to translate their work into new operating companies. The check size reflects the formation focus rather than later-stage growth participation, with subsequent capital raised from broader syndicates as ventures mature.

For founders, NLC Health Ventures is most relevant for medical researchers, clinicians, and inventors with a healthcare innovation that needs a partner to help build a company around it. Expect engagement that goes well beyond capital, including co-founding work, IP and regulatory positioning, and operational scaffolding for the early years. Researchers who already have a complete management team and an organized company may find the venture builder model less relevant. The strongest match is an inventor whose innovation is genuinely promising but who needs structure, capital, and execution capacity to translate it into a venture-backable business.